首页> 外文OA文献 >Evaluation of ACMG Rules for In silico Evidence Strength Using An Independent Computational Tool Absent of Circularities on ATM and CHEK2 Breast Cancer Cases and Controls

【2h】

Evaluation of ACMG Rules for In silico Evidence Strength Using An Independent Computational Tool Absent of Circularities on ATM and CHEK2 Breast Cancer Cases and Controls

机译：利用ATM和CHEK2乳腺癌病例和对照的循环缺席缺乏循环的独立计算工具评估硅证据强度的ACMG规则

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Colin C. Young; Bing-Jian Feng; Colin B. Mackenzie; Elodie Girard; Donglei Hu; Yusuke Iwasaki; Yukihide Momozawa; Fabienne Lesueur; Elad Ziv; Susan L. Neuhausen; Sean V. Tavtigian;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
专利

1. Breast cancer screening implications of risk modeling among female relatives of ATM ATM and CHEK2 CHEK2 carriers [J] . Weidner Anne E., Liggin Mariel E., Zuniga Brenda I., Cancer: A Journal of the American Cancer Society . 2020,第8期

机译：乳腺癌筛查atm atm和Chek2 Chek2载体的女性亲属风险建模的影响
2. Points to consider: is there evidence to support BRCA1/2 and other inherited breast cancer genetic testing for all breast cancer patients? A statement of the American College of Medical Genetics and Genomics (ACMG) [J] . Genetics in medicine . 2020,第4期

机译：要考虑的要点：是否有证据支持所有乳腺癌患者的BRCA1 / 2和其他遗传乳腺癌遗传学检测？美国医学遗传学和基因组学院的陈述（ACMG）
3. Assessing the performance of in silico methods for predicting the pathogenicity of variants in the gene CHEK2, among Hispanic females with breast cancer [J] . Voskanian Alin, Katsonis Panagiotis, Lichtarge Olivier, Human mutation . 2019,第9期

机译：评估用于预测基因CHEK2中变异致病性的三种方法的性能，与乳腺癌的西班牙裔女性
4. Evaluation of anti-cancer therapy using in silico analysis of treatments for HER2#x002B; breast cancer [C] . Ganic E., Gundry S., Jianmin Zou, 2014 IEEE International Symposium on Medical Measurements and Applications . 2014

机译：使用计算机分析HER2 +乳腺癌的治疗方法评估抗癌治疗
5. Segregation analyses in Ashkenazi Jewish families: Evidence of an additional breast cancer susceptibility gene, and evaluation of cancer risks in BRCA1/2 mutation carriers. [D] . Kaufman, David J. 2002

机译：阿什肯纳兹犹太人家庭的隔离分析：另一个乳腺癌易感基因的证据，以及BRCA1 / 2突变携带者的癌症风险评估。
6. CHEK2*1100delC and Susceptibility to Breast Cancer: A Collaborative Analysis Involving 10860 Breast Cancer Cases and 9065 Controls from 10 Studies [O] . 2004

机译：CHEK2 * 1100delC与乳腺癌的易感性：一项涉及10860例乳腺癌病例和9065例对照的协作分析
7. Points to consider: is there evidence to support BRCA1/2 and other inherited breast cancer genetic testing for all breast cancer patients? A statement of the American College of Medical Genetics and Genomics (ACMG) [O] . Tuya Pal, Doreen Agnese, Mary Daly, 2019

机译：要考虑的要点：是否有证据支持所有乳腺癌患者的BRCA1 / 2和其他遗传乳腺癌遗传学检测？美国医学遗传学和基因组学院的陈述（ACMG）

Evaluation of ACMG Rules for In silico Evidence Strength Using An Independent Computational Tool Absent of Circularities on ATM and CHEK2 Breast Cancer Cases and Controls

著录项

引文网络

相似文献

相关主题

期刊订阅